Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: a meta‐analysis
… This systematic review synthesized 90 studies with direct comparisons of two or three EGFR
TKIs, the majority of which comparing gefitinib with erlotinib. It was found that gefitinib had …
TKIs, the majority of which comparing gefitinib with erlotinib. It was found that gefitinib had …
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
JY Wu, SG Wu, CH Yang, YL Chang, YC Chang… - Lung cancer, 2011 - Elsevier
… according to different lines of gefitinib or erlotinib. The disparities of choices on gefitinib or
erlotinib (more male, non-adenocarcinoma and smokers using erlotinib) were still noted in all …
erlotinib (more male, non-adenocarcinoma and smokers using erlotinib) were still noted in all …
[HTML][HTML] Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
YY Shao, WY Shau, ZZ Lin, HM Chen, R Kuo… - European Journal of …, 2013 - Elsevier
… Patients who used either gefitinib or erlotinib as second-line therapy were excluded. We
did not plan to analyse gefitinib or erlotinib as second-line therapy because erlotinib gained …
did not plan to analyse gefitinib or erlotinib as second-line therapy because erlotinib gained …
Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… The erlotinib group also showed more of a tendency to … ; our data suggest that gefitinib and
erlotinib might have almost … , although erlotinib appears to have higher toxicity than gefitinib …
erlotinib might have almost … , although erlotinib appears to have higher toxicity than gefitinib …
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… We have preliminary results of phase III clinical studies comparing … -1 clinical trial) and
erlotinib or gefitinib in first-line treatment of … studies comparing gefitinib, erlotinib, and afatinib. …
erlotinib or gefitinib in first-line treatment of … studies comparing gefitinib, erlotinib, and afatinib. …
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy
… Cancer trial comparing gefitinib with placebo in patients with advanced NSCLC who had
failed prior chemotherapy did not show any significant improvement of survival with gefitinib in …
failed prior chemotherapy did not show any significant improvement of survival with gefitinib in …
[HTML][HTML] Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer
YY Shao, CC Lin, CH Yang - Discovery Medicine, 2010 - discoverymedicine.com
… The adequate-powered, direct comparisons of gefitinib against erlotinib under the same
clinical scenarios are lacking. There is no evidence at present that the efficacy of these two …
clinical scenarios are lacking. There is no evidence at present that the efficacy of these two …
Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Y Liu, Y Zhang, G Feng, Q Niu… - Experimental and …, 2017 - spandidos-publications.com
… MST compared with gefitinib and icotinib (P<0.05). In conclusion, gefitinib, erlotinib and
icotinib … However, gefitinib resulted in a lower frequency of fatigue, and nausea and vomiting, …
icotinib … However, gefitinib resulted in a lower frequency of fatigue, and nausea and vomiting, …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - journals.lww.com
… Comparison of effectiveness (PFS) of erlotinib and gefitinib: The PFS for each drug was
estimated from the number of days without disease progression and was compared (Figure). …
estimated from the number of days without disease progression and was compared (Figure). …
[HTML][HTML] A retrospective comparison of the clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients with non-small cell lung cancer
A Fujiwara, M Yoshida, H Fujimoto, H Nakahara… - Oncology …, 2018 - ncbi.nlm.nih.gov
… three available EGFR TKIs (gefitinib, erlotinib, and afatinib) for the … However, whether gefitinib,
erlotinib, or afatinib is most … to compare the effectiveness of gefitinib, erlotinib, and afatinib. …
erlotinib, or afatinib is most … to compare the effectiveness of gefitinib, erlotinib, and afatinib. …
相关搜索
- tyrosine kinase inhibitors gefitinib and erlotinib
- egfr gefitinib and erlotinib
- gefitinib and erlotinib cell lung cancer
- gefitinib and erlotinib growth factor receptor
- gefitinib and erlotinib non-small cell
- nsclc gefitinib and erlotinib
- gefitinib and erlotinib first generation
- gefitinib and erlotinib mutations
- gefitinib and erlotinib receptor
- gefitinib and erlotinib factor
- gefitinib and erlotinib small molecule
- gefitinib and erlotinib efficacy
- gefitinib and erlotinib egfr tyrosine kinase
- gefitinib and erlotinib epidermal growth factor
- gefitinib and erlotinib nsclc patients
- cetuximab gefitinib and erlotinib